An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Nuwellis, Inc. (NUWE) will report its first quarter 2024 financial results on May 7, 2024. The medical technology company will host a conference call and webcast to discuss the results and provide a business update.
Nuwellis, Inc. (NUWE) comunicherà i risultati finanziari del primo trimestre del 2024 il 7 maggio 2024. La compagnia operante nel settore delle tecnologie mediche terrà una teleconferenza e un webcast per discutere i risultati e fornire un aggiornamento sulle attività aziendali.
Nuwellis, Inc. (NUWE) reportará los resultados financieros del primer trimestre de 2024 el 7 de mayo de 2024. La empresa de tecnología médica organizará una llamada de conferencia y un webcast para discutir los resultados y proporcionar una actualización de los negocios.
Nuwellis, Inc.(NUWE)는 2024년 1/4분기 재무 결과를 2024년 5월 7일에 발표할 예정입니다. 이 의료 기술 회사는 결과를 논의하고 사업 업데이트를 제공하기 위해 컨퍼런스 콜과 웹캐스트를 주최할 것입니다.
Nuwellis, Inc. (NUWE) publiera ses résultats financiers pour le premier trimestre 2024 le 7 mai 2024. La société de technologie médicale organisera une conférence téléphonique et un webcast pour discuter des résultats et fournir une mise à jour sur les activités de l'entreprise.
Nuwellis, Inc. (NUWE) wird am 7. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 bekannt geben. Das Unternehmen für Medizintechnik wird eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu diskutieren und ein Geschäftsupdate zu geben.
Positive
None.
Negative
None.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter of 2024 on Tuesday, May 7, 2024. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.
To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-833-816-1404 (U.S) or 1-412-317-0497 (international) and using the conference ID: 10188299. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit ir.nuwellis.com or visit us on LinkedIn or X.
About the Aquadex SmartFlow® System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
CONTACTS
INVESTORS: Vivian Cervantes Gilmartin Group LLC ir@nuwellis.com
FAQ
When will Nuwellis, Inc. report its first quarter 2024 financial results?
Nuwellis, Inc. will report its first quarter 2024 financial results on May 7, 2024.
What is the stock symbol for Nuwellis, Inc.?
The stock symbol for Nuwellis, Inc. is NUWE.
How can I access the live webcast of the financial results discussion?
To access the live webcast, visit the Investors page of the Nuwellis website at https://ir.nuwellis.com.
What are the conference call details to discuss the financial results?
You can access the live conference call by dialing 1-833-816-1404 (U.S) or 1-412-317-0497 (international) using the conference ID: 10188299.
Will an audio archive be available after the conference call?
Yes, an audio archive of the webcast will be available on the Investors page at https://ir.nuwellis.com.
chf solutions is an early stage company focused on commercializing the aquadex flexflow system. our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. at chf solutions, we are committed to the relentless pursuit of identifying and developing innovative solutions to address unmet clinical needs with the goal of benefiting patients, medical practitioners, and the broader healthcare community. if you are looking for a career where you can make difference we would like to hear from you. we are looking for highly skilled, highly motivated people who want to be part of a growing company where everything you do will matter. chf solutions is an equal opportunity/affirmative action employer committed to cultural diversity in the workplace.
